INTRODUCTION
Lithium salts are widely used in the therapy of bipolar disorder [1] . A hallmark of the therapeutic concept of lithium treatment is the chronic administration. To achieve the mood-stabilizing and phase prophylactic action, treatment with lithium for several months has been shown to be necessary. Although the effectiveness of lithium is indisputable, its mechanism of action is still poorly understood. Some molecular targets for lithium have been identified. Among those are enzymes such as adenylate cyclase, GSK3β (glycogen synthase kinase 3β) and IMP (inositol monophosphatase) [2] . The univalent cation of lithium is able to inhibit these enzymes and thereby subsequently induce changes in second messenger levels and signalling cascades which are thought to contribute to the therapeutic action of lithium. However, these changes occur immediately and therefore are not sufficient to explain the extremely delayed onset of the therapeutic action. Thus, subsequent to early changes in enzyme activities, particularly long-lasting adaptive neuronal processes are suggested to be involved. Indeed, lithium-induced plasticity could be shown in hippocampal neurons both in vitro and in vivo after chronic treatment [3] . The molecular basis for these adaptive changes is the expression of genes regulated by transcription factors. Thus transcription factors could be a target of lithium, initiating changes in gene expression, which can be summarized as neuronal adaptation. One important transcription factor in the brain is CREB (cAMP-response-element-binding protein). CREB is involved in adaptive processes such as learning, memory [4] and opioid-induced addiction [5] . Among the CREB-regulated genes there are several involved in neurotransmission and signalling [6] .
CREB belongs to the family of basic leucine zipper transcription factors which contain C-terminally a leucine zipper dimerization domain and a basic region, by which the CRE (cAMP-responsive element) is bound [7] . CREB can be activated by various signalling pathways, which converge in the phosphorylation of Ser 119 located in the transactivation domain. Transactivation of transcription is accomplished by the recruitment of coactivators, which interact with the basal transcription machinery. In addition to the long-known coactivator CBP (CREB-binding protein) [7] which binds to the phosphorylated transactivation domain, more recently another coactivator has been discovered. TORC (transducer of regulated CREB activity), an 80 kDa protein which exists in three isoforms [8] , binds to the bZip (basic leucine zipper domain) and contributes to the transcriptional activity of CREB.
There have been few studies on the action of lithium on CREB. The majority of them focus on the phosphorylation of CREB [9] [10] [11] and its DNA binding [12, 13] . However, the DNA binding of CREB plays a minor role in the regulation of its activity, as non-phosphorylated CREB is also able to bind the CRE
Figure 1 Effect of lithium on forskolin-stimulated CRE/CREB-directed gene transcription
HIT-T15 cells were transfected with the indicated reporter gene construct 4 × SomCRET81Luc. At 7 h prior to harvest, cells were treated with 20 mM LiCl and 6 h prior to harvest with 10 µM forskolin. At 48 h after transfection, luciferase activity was determined. Values are expressed as a percentage of the controls that received solvent only. Values are means + − S.E.M. for four independent experiments each performed in duplicate. FSK, forskolin; TK, thymidine kinase promoter. ***P < 0.001, two-way ANOVA, Bonferroni post-hoc test. [7] . Furthermore, it has been shown previously [14] [15] [16] that phosphorylation is a necessary prerequisite for the transcriptional activation of CREB, but is not sufficient. Therefore CREB activity cannot be determined by measuring its phosphorylation or DNA binding alone but rather by determining the expression of a CRE/CREB-driven gene. Thus in the present study we focus on the effect of lithium on the transcriptional activity of CREB as revealed by CRE-or GAL4-system-driven luciferase reporter gene constructs. The expression of the reporter gene records the complete process, including DNA binding, phosphorylation and also the recruitment of coactivators.
The present study shows that lithium strongly enhances cAMPstimulated CRE-mediated transcription and CREB activity. This effect depends on the bZip. Furthermore, TORC was shown to confer lithium responsiveness on CREB-bZip. Thus the present study, for the first time, identifies the CREB-bZip in combination with the coactivator TORC as a new molecular target of lithium.
EXPERIMENTAL

Plasmids
Reporter gene constructs used for transfection were 4×SomCRET81Luc [17] containing the luciferase gene under the control of four repeats of the CRE from the somatostatin promoter and a truncated thymidine kinase promoter ( Figure 1) ; − 65SMSLuc, containing the luciferase gene under control of the truncated rat somatostatin promoter (− 65 to + 54) [18] ; and 5×Gal4E1B-Luc [19] , which contains the luciferase gene under control of five repeats of the responsive element for the yeast transcription factor GAL4. Expression vectors for the overexpression of GAL4-CREB fusion proteins were GAL4-CREB 327 [20] , encoding full length CREB, GAL4-CREB 261 [21] , which encodes a truncated CREB lacking the basic region and bZip, and GAL4-CREB-R300A. The GAL4-CREB-R300A mutant was generated by primerless PCR using the following primers (mutation underlined): 5 -TGTTTAG-AAAACGCAGTGGCAGTGCTT-3 (forward), 5 -AAGCACTG-CCACTGCGTTTTCTAAACA-3 (reverse), flanking primers and GAL4-CREB327 as a template. For PCR cloning of GAL4-bZip encoding the bZip (CREB 262−327 ), the primers 5 -CGCGGATCCTAGCACGAAAGAGAGAGGTCC-3 (forward) (BamHI site in italics, coding sequence underlined), 5 -CGCTCTAGATTATTAATCTGATTTGTGGCAGTAAAGGTC-3 (reverse) (XbaI site in italics, stop codons bold, coding region underlined), and GAL4-CREB 327 as a template were used followed by cloning into the GAL4 domain-coding vector pSG424. The TORC1-coding sequence was kindly provided by Marc Labow (Novartis Pharma AG, Basel, Switzerland) and subcloned into pcDNA3.
Cell culture, transfection and stimulation
Hamster insulinoma tumour cells (HIT-T15) [18] were grown in RPMI 1640 medium supplemented with 10 % fetal calf serum, 5 % horse serum, 100 units/ml penicillin and 100 µg/ml streptomycin. The cells were transiently transfected using the DEAE-dextran method [18] with 2 µg of the indicated plasmid per 6-cm-diameter dish.
Cytomegalovirus green fluorescent protein expression vectors (1 µg per 6-cm-diameter dish) were added as second reporters to control for transfection efficiency. Cells were treated with 1 mM myoinositol 8 h prior to harvest, with 20 mM LiCl or the GSK3β inhibitors SB215763 (30 µM) or SB415286 (50 µM) 7 h prior to harvest, and with 1 or 2 mM 8BrcAMP (8-bromocAMP), 40 mM KCl or 10 µM forskolin 6 h prior to harvest. Cell extracts were prepared 48 h after transfection. The luciferase assay was performed as previously described [18] . Fluorescence of the green fluorescent protein was measured in a Packard FluoroCount fluorimeter with the excitation wavelength at 485 nm and emission wavelength at 530 nm. For the determination of the intracellular lithium concentration, cells were lysed by freeze-thaw cycles and the lithium concentration in supernatants was measured by ionselective potentiometry using an Easylyte Na/K/Li analyser.
Western blot analysis
For CREB/phospho-CREB determination, HIT-T15 cells were treated 3 h prior to harvest with 20 mM LiCl and 2 h prior to harvest with 2 mM 8BrcAMP. For measurement of β-catenin accumulation, the cells were treated 6 h prior to harvest with 20 mM LiCl or the GSK3β inhibitors SB215763 (30 µM) or SB415286 (50 µM). Proteins in the cell lysates were separated by SDS/PAGE (10 % gels) and transferred on to nitrocellulose membrane by semi-dry blotting. CREB, phospho-CREB or β-catenin was immunostained with specific antibodies and respective peroxidaselabelled secondary antibodies. Immunoreactivity was detected using ECL ® (enhanced chemiluminescence; GE Healthcare).
Specific bands were quantified densitometrically, and the ratio between the intensity of CREB and phospho-CREB from the same lysate was calculated. For β-catenin blots, identical loading was assured by using GAPDH (glyceraldehyde-3-phosphate dehydrogenase) as a control.
EMSA (electrophoretic mobility-shift assay)
For EMSA, HIT-T15 cells were treated with 20 mM LiCl 2 h prior to harvest and with 2 mM 8BrcAMP 1 h prior to harvest. Nuclear extracts were prepared as described by Schreiber et al. [22] . The synthetic complementary oligonucleotides SCE (somatostatin CRE) [17] with 5 -GATC overhangs were annealed and labelled by a fill-in reaction using [α- 32 P]dCTP and Klenow enzyme. Using 11 µg of protein from the nuclear extracts, EMSA was performed as described previously [23] . Briefly, nuclear extracts were incubated in a total volume of 20 µl containing 20 mM Hepes (pH 7.9), 1 mM EDTA, 0.5 mM dithiothreitol, 5 mM MgCl 2 , 70 mM KCl, 10% (v/v) glycerol and 0.2 µg of poly(dI-dC) as a non-specific competitor and 16 pmol of unlabelled wild-type or mutant SCE as specific competitor, if indicated, for 10 min on ice. Then, 20 000 c.p.m. of the labelled probe was added and incubated for 15 min on ice. Proteins were separated on a 5% non-denaturing PAGE gel and bound probes detected by autoradiography.
Measurement of intracellular calcium [Ca 2+ ] i
HIT-T15 cells were subcultured on coverslips at 37
• C in medium containing 130 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 1.5 mM CaCl 2 , 6 mM glucose, 20 mM Hepes and 2 % (w/v) BSA (pH 7.4), aerated with 100
Where indicated, cells were pretreated with 20 mM LiCl for 1 h before loading with 5 µM fura-2/AM (fura 2 acetoxymethyl ester), in the presence of 0.1 % (w/v) Pluronic F-127 at 37
• C for 30 min. After loading, the coverslips were washed, mounted in a temperature-controlled superfusion chamber (37
• C) and placed on the platform of a Carl Zeiss Axiovert IM 135 microcope equipped with a 40× Achrostigmat oil-immersion objective. The chamber was superfused with the same buffer as above with 0.1 % (w/v) BSA, without 0.1 % (w/v) Pluronic F-127 and the respective test agents at a flow rate of 0.75 ml/min. Ca 2+ measurements were taken on cells of average size and healthy appearance (round in shape with no membrane blebs). Fura-2 fluorescence from single cells was recorded with a dual excitation spectrofluorimeter system (Deltascan 4000, Photon Technology Instruments). [Ca 2+ ] i was calculated according to the formula
where K d = 225 nM [24] and R max , R min and B are constants that were determined in the superfusion chamber from solutions containing fura-2 free acid (1 µM) and various concentrations of free Ca 2+ (results not shown). All records were corrected for autofluorescence of unloaded cells at each wavelength before the ratio was used.
Materials
All reagents, unless otherwise indicated, were from SigmaAldrich. Stock solutions were prepared in water, except for forskolin, SB215763 and SB415286 which were prepared in DMSO. Controls received the solvent only. [α-
32 P]dCTP and the ECL ® system was obtained from GE Healthcare. All enzymes were purchased from Fermentas. SB215763 and SB415286 were obtained from GlaxoSmithKline. The phospho-CREB antibody was from NewEngland Biolabs and the β-catenin antibody was from BD Biosciences.
Statistics
All analyses (two-way ANOVA with Bonferroni post-hoc test, Student's t test) as indicated in the legends to the Figures were performed using the software STATISTICA 7.1 (Statsoft).
RESULTS
To investigate the effect of lithium salts on CRE-directed gene transcription, a transient transfection assay was used. The electrically excitable hamster insulinoma tumour cell line HIT was transfected with a DNA construct in which the expression of a reporter gene is controlled by the CRE from the rat somatostatin promoter. This CRE contains the consensus sequence TGACGTCA and is well-known as a high-affinity CREB-binding site that mediates responsiveness to cAMP and Ca 2+ [17] . The construct ( Figure 1 ) containing four copies of the CRE in front of the truncated viral thymidine kinase promoter and the luciferase gene, has been characterized before in HIT cells [25] . The CRE conferred negligible low basal transcriptional activity (Figure 1) . Stimulation with the adenylate cyclase activator forskolin resulted in a 27.5-fold increase of CRE-mediated transcription, as described previously [25] . For lithium treatment, a concentration of 20 mM was chosen. This concentration resulted in an intracellular lithium concentration of 3.2 + − 0.2 mM. Treatment with 20 mM LiCl only slightly increased basal CRE activity (result not significant); Figure 1 ). In contrast, lithium treatment resulted in a decrease of forskolin-induced CRE activity by 41 % (Figure 1 ). This decrease is most probably due to the inhibition of the adenylate cyclase activity by lithium [26] as the measurement of intracellular cAMP levels indicated markedly reduced levels after lithium treatment (results not shown).
Enhancement of cAMP-induced transcription by lithium
To test whether, in addition to its effect on cAMP formation, lithium can influence cAMP-induced transcription, HIT cells were stimulated with 8BrcAMP, an analogue for cAMP with a higher stability and increased membrane permeability. Stimulation with 1 mM 8BrcAMP resulted in a 4.7-fold increase in CRE-mediated transcription (Figure 2 , left-hand panel). In contrast with the effect on forskolin stimulation, lithium in combination with 8BrcAMP exerted a robust enhancing effect on CREB activity by 22.3-fold. Relative to the 8BrcAMP-induced stimulation, lithium treatment resulted in a 4.7-fold increase ( Figure 2) .
As HIT cells are electrically excitable [25] , we sought to determine whether lithium could influence calcium-induced CREmediated transcription [25] . HIT cells were treated with 40 mM KCl to induce membrane depolarization and subsequent calcium influx. Membrane depolarization led to a 6.5-fold increase of CRE-mediated transcription (Figure 2 , left-hand panel). Lithium treatment increased depolarization-induced CRE activity only 1.39-fold, which was not significant. In contrast, the combined stimulus of 8BrcAMP plus depolarization, which resulted in a 140-fold increase of CRE-mediated gene transcription, was further enhanced by lithium 1.8-fold (Figure 2 , right-hand panel), which was highly significant. Since lithium enhanced transcription not only after stimulation by cAMP, but also after stimulation by cAMP plus KCl, lithium may affect transcription, although not through an increase in cytosolic calcium concentrations. For further investigation, the intracellular calcium levels of HIT cells after different stimuli were recorded. LiCl (20 mM) did not change the basal intracellular Ca 2+ level [180 + − 3 nM (control) compared with 176 + − 5 nM (lithium)]. Stimulation with 2 mM 8BrcAMP increased intracellular Ca 2+ by 84 + − 16 nM. Pretreatment with lithium resulted in a slight decrease in the calcium rise (38 + − 11 nM), which was not significant (as determined using the Student's t test). Stimulation with both 8BrcAMP and KCl increased Ca 2+ levels by 226 + − 25 nM over basal levels. Pretreatment with lithium had no effect (218 + − 37 nM). The results support the notion that the enhancing effect of lithium on CRE-mediated transcription is not caused by elevated intracellular calcium levels.
To examine whether the concentration-response relationship of the effect of lithium on 8BrcAMP-stimulated CRE activation was dose-dependent, increasing concentrations of lithium were employed. A significant enhancing effect of lithium was detectable at 6 mM (2.3-fold increase of 8BrcAMP-induced activity; Figure 3 ). Higher concentrations (20 and 50 mM LiCl) enhanced 8BrcAMP-induced activity about 4-fold ( Figure 3 ) and 11.4-fold respectively (results not shown). The dose-response curve did not show a sigmoidal characteristic, as it reached no maximum. Thus a half-maximal effective dose could not be calculated.
Role of the known lithium targets GSK3β and IMP
Lithium salts are known to inhibit GSK3β and IMP [2] . Therefore the question was addressed as to whether these two enzymes were involved in the effect of lithium on CRE-mediated gene transcription.
Two different GSK3β inhibitors were used. Neither SB216763 nor SB415286 mimicked the effect of lithium (Figure 4a) . SB216763, SB415286 and lithium-induced β-catenin accumulation indicated efficient inhibition of GSK3β (results not shown).
Lithium inhibits IMP and thus depletes inositol in the cell [2] . Therefore cells were treated concurrently with inositol to replenish a presumed depletion in inositol storage. The addition of inositol did not change the effect of lithium on 8BrcAMP-induced CRE-mediated transcription (Figure 4b ). Thus these well known biochemical targets of lithium most probably were not responsible for the stimulation of CRE-mediated transcription by lithium.
Effect of lithium on CREB phosphorylation and CRE binding
An important step in the activation of CREB is its phosphorylation on Ser 119 . Therefore the ratio of phosphorylated to nonphosphorylated CREB was determined by Western blot analysis. Treatment with lithium alone did not change the ratio of phospho-CREB to CREB ( Figure 5 ). 8BrcAMP induced a slight 1.3-fold increase in CREB phosphorylation. This phosphorylation was not HIT-T15 cells were transfected with the reporter gene construct 4×SomCRET81Luc. At 7 h prior to harvest, cells were treated with increasing concentrations of LiCl (20 µM-20 mM) and 6 h prior to harvest with 1 mM 8BrcAMP. At 48 h after transfection, the luciferase activity of the cells was determined. Values for 8BrcAMP-treated cells that received no LiCl were set to 100 %. Values are means + − S.E.M. for three independent experiments each performed in duplicate. *P < 0.05, **P < 0.01, Student's t test.
detectably changed by lithium ( Figure 5 ). However, as the values only approached significance (P = 0.065, one-way ANOVA), probably because of the low 8BrcAMP concentration, these are only tendencies which most probably do not account for the observed effect of lithium on CRE-mediated transcription. Another possibility for the action of lithium on CRE-mediated gene transcription could be the modulation of the DNA binding of CREB. Therefore EMSAs with nuclear extracts from lithiumtreated cells and the somatostatin CRE were performed. Nuclear CREB binding to the CRE was clearly detectable, as shown previously [17] (Figure 6a ). The specificity of the band was confirmed in competition experiments. Adding an excess of unlabelled CRE markedly decreased the intensity of the band to 8.7 % of control, whereas a similar excess of a mutant CRE was almost ineffective (a decrease to 76.1 % of control).
The DNA binding of CREB was not changed by any treatment ( Figure 6b ) (P = 0.9, effect of treatment, two-way-ANOVA). Thus the enhancement of CRE-mediated gene transcription was not related to an effect of lithium on the binding of CREB to its responsive element as revealed by EMSA.
Lithium responsiveness depends on the CREB-bZip
To further investigate the mechanism of the observed action of lithium on CREB-mediated transcription the GAL4 system was employed. Expression vectors encoding the DNA-binding domain of the yeast transcription factor GAL4 fused to the transcription factor of interest were co-transfected with a GAL4-binding-site-driven luciferase reporter gene. This allowed the investigation of the transactivational potential of the transcription factor of interest, independent from its DNA binding and endogenous background. The GAL4 domain itself did not show any responsiveness to the stimuli used (results not shown).
When full-length CREB was fused to the GAL4 DNAbinding domain (GAL4-CREB) the treatment with 8BrcAMP and lithium mimicked the effect observed when using the CREdriven promoter (Figure 7) . At 20 mM concentration, LiCl alone had no effect on gene transcription. The combination of lithium with the cAMP stimulus resulted in a robust enhancement of gene transcription [2.9-fold over 8BrcAMP alone (Figure 7) ]. To test whether the lithium effect depends on the bZip domain of CREB, a truncated mutant of CREB (amino acids 1-261) was fused to GAL4 (GAL4-CREB 261 ). This construct contains the transactivation domain of CREB (including Ser 119 ) but lacks the bZip of CREB. With GAL4-CREB 261 , the lithium effect was completely abolished (Figure 7) . Stimulation with 20 mM LiCl increased transcription only slightly, 1 mM 8BrcAMP increased transcription 1.6-fold, and the combination of both stimuli increased transcription 2.43-fold, which did not reach significance (two-way ANOVA) (Figure 7 ). Thus the bZip domain seemed to be crucial to confer the lithium effect on CREB.
The coactivator TORC confers lithium responsiveness
As the coactivator TORC binds to the bZip [8] , the involvement of TORC in the lithium effect was tested. A CREB mutant with a replacement of Arg 300 with an alanine residue in the bZip has been reported to be deficient in TORC binding [27] . Thus a GAL4-CREB-R300A mutant was employed (Figure 8a) . As reported previously, this mutant responded only poorly to the cAMP stimulus [27] and also lithium failed to induce a significant enhancement (Figure 8a) . To confirm the importance of the bZip and TORC for the lithium effect, a construct containing the GAL4-DNA-binding domain fused to the isolated CREB-bZip was employed (GAL4 -bZip). Without co-transfection, the bZip showed no activation by cAMP and lithium (Figure 8a) . However, when TORC1 was overexpressed, the bZip was activated by 8BrcAMP and more importantly, the lithium effect was also restored completely (2.4-fold increase relative to the cAMP stimulus) (Figure 8a ). GAL4 and GAL4-bZip-R300A were not activated by TORC overexpression (results not shown).
Finally, we tested whether TORC could also confer the lithium effect on a native promoter. Therefore a promoter (− 65SMSLuc) containing one CRE in its homologous context was employed. The truncated promoter showed only poor response to either stimulus (Figure 8b ). In contrast, after overexpression of TORC1, lithium was able to enhance the cAMP-stimulated promoter activity 1.94-fold (Figure 8b ). Thus as shown with the GAL4-system and a native promoter, TORC is able to confer the lithium-induced enhancement of cAMP-stimulated CREB activity.
DISCUSSION
Lithium salts have been established for more than 50 years as the most effective treatment for bipolar disorder [1] . Lithium salts have an acute silencing action, making them beneficial for the treatment not only of manic phases of bipolar disorder but also of psychotic manic states. More important, they are the only treatment that prevents the cycling between manic and depressive states and also reduces the suicide rate [28] . The requirement of chronic treatment of up to several months implicates the involvement of changes in gene expression based on the modulation of transcription factors such as CREB.
CREB has been implicated in several important brain functions. In addition to physiological functions such as learning and HIT-T15 cells were transfected with either the GAL4-driven reporter gene construct G5E1B-Luc and GAL4-fusion proteins containing full length CREB mutant R300A or CREBbZip (a) or the truncated rat somatostatin promoter-driven reporter gene − 65SMSLuc (b). Expression vector for TORC1 was co-transfected where indicated. At 7 h prior to harvest, cells were treated with 20 mM LiCl and 6 h prior to harvest with 2 mM 8BrcAMP. At 48 h after transfection, luciferase activity was determined. Values are expressed as a percentage of the respective untreated control. Values are means + − S.E.M. for three independent experiments each performed in duplicate. ***P < 0.001, two-way ANOVA, Bonferroni post-hoc test.
memory [4] there is evidence that CREB also plays a role in the development of mental diseases [29] . Both major depression and bipolar disorder are thought to be related to changes in the cAMP/PKA (protein kinase A)/CREB system, and treatment with antidepressants and mood stabilizers are suggested to correct for deficits in neuronal signalling [30] .
In the present study, the action of the clinically well-established mood stabilizer lithium on CRE/CREB-driven gene transcription was investigated. The major findings were (i) lithium induces a robust increase in cAMP-stimulated CRE-driven gene transcription and enhances CREB activity; (ii) this effect of lithium does not appear to be related to an enhanced CREBSer 119 phosphorylation, an increased CREB-DNA binding or the inhibition of GSK3β and IMP; and (iii) the enhancement by lithium of CREB activity seems to be conferred by the coactivator TORC binding on the CREB-bZip.
To study the effect of lithium on CRE/CREB-directed gene transcription, a luciferase reporter gene construct was employed where reporter gene expression was regulated by four repeats of the somatostatin CRE. This CRE contains the palindromic core binding site with the consensus sequence 5 -TGACGTCA-3 . In combination with the flanking regions, the somatostatin CRE forms a binding site with a notably high affinity for CREB [7] . The 4×SomCRET81Luc construct has been thoroughly characterized in the pancreatic β-cell line HIT-T15 [17, 25] as well as in other cells, including neuronal cell lines [19] . HIT-cells resemble neuronal cells in important aspects. They are electrically excitable, express calcium and potassium channels and also have neuronspecific transcription factors.
Lithium induced a robust increase in 8BrcAMP-induced CRE/CREB-directed gene transcription. The dose-response curve showed a significant effect with 6 mM lithium. The measurement of the cytosolic lithium concentration revealed that the intracellular level of lithium was about 6-fold lower than in the cell culture medium. As plasma levels of 1 mM lithium have been proven to be effective in patients, we conclude that lithium at therapeutic concentrations is able to increase CRE/CREB transcriptional activity.
A simple explanation for the effect of lithium could be an induction of calcium influx, since the combination of calcium and cAMP stimuli has been shown to be superadditive in the activation of CRE/CREB-directed gene transcription [17] . However, the combined stimulus, 8BrcAMP plus KCl, was also enhanced by lithium. Moreover, the determination of intracellular calcium concentrations revealed, if anything, rather decreased calcium levels by lithium after cAMP-stimulation. This could be due to an enhanced efflux of calcium caused by a replacement of sodium by lithium in a sodium/calcium exchanger which has been reported previously [31] .
Two well-known targets of lithium are IMP and GSK3β [2] . Both do not appear to be involved in the observed effect of lithium on CRE-driven gene transcription. IMP inhibition and subsequent inositol depletion have been suggested to be the common mechanism of action of three mood stabilizing agents [32] as lithium, valproate and carbamazepine stabilized neuronal growth cones in an inositol-reversible manner. However, the action of lithium on CRE/CREB-directed transcription was not affected by the addition of inositol, which should prevent the assumed inositol depletion by lithium. GSK3β has been shown to be inhibited by lithium at concentrations of approx. 1-2 mM [33] and is thought to mediate the therapeutic effects of lithium [34] . As CREB is phosphorylated by GSK3β on Ser 115 [35] , lithium may influence CREB activity via GSK3β. It has been shown that the phosphorylation of CREB by GSK3β reduces the DNA binding of CREB and thus attenuated CREB activity [12] . However, in the present study, two specific GSK inhibitors did not mimic the effect of lithium on CRE/CREB-directed gene transcription. Moreover, EMSA revealed no effect of lithium on CREB DNAbinding. Of note, lithium and the two GSK3β inhibitors induced an accumulation of β-catenin, indicating that GSK3β was active and the inhibitors were effective. Thus inhibition of GSK3β most probably does not contribute to the effect of lithium on cAMPinduced CRE/CREB-directed gene transcription.
As the two best known lithium targets seemed not to be involved, we focused on the effect of lithium on CREB activity. Western blot analyses revealed that the robust enhancement of cAMP-induced CRE/CREB-directed gene transcription was not accompanied by an increased phosphorylation of CREB. Unchanged CREB phosphorylation after lithium treatment of an osteoblastic cell line [36] or in cerebellar granule cells of acutely treated rats [11] has been shown previously. Moreover, in addition to lacking impact on CREB phosphorylation, it was shown that the lithium effect was not dependent on the Ser 119 -containing transactivation domain, but required the existence of the CREBbZip. In the present study we confirm a discrepancy between CRE/CREB-mediated transcription and phosphorylation, which has been reported previously in HIT cells after cyclosporin A treatment [14] or in cortical [15] and hippocampal neurons [16] . Until recently, CREB transcriptional activity was generally explained by the classic transactivation pathway of CREB e.g. phosphorylation of Ser 119 and recruitment of CBP, though the involvement of additional factors has also been assumed [37] .
Recently, a new coactivator has been discovered, namely TORC [8] . TORC confers CREB transactivation by binding to the CREBbZip independent of phosphorylation at Ser 119 . TORC exists in three isoforms and has been shown to be localized under basal conditions in the cytosol. Upon stimulation with cAMP it translocates to the nucleus and binds to the leucine zipper of CREB where it contributes to transcriptional activity. As the effect of lithium on CREB activity and the action of TORC converge at the CREB-bZip, the involvement of TORC into the lithium action was shown. Three approaches were used. First, Arg 300 which has been shown to be crucial for the CREB-TORC interaction was mutated to an alanine residue. In this case, lithium failed to induce an enhancement of CREB activity. Secondly, the isolated CREBbZip showed activation neither by cAMP nor by lithium; however, overexpression of recombinant TORC completely restored the lithium effect. As the isolated CREB-bZip was not sufficient to mediate the lithium effect, one could assume that the recruitment of endogenous TORC was less stable or occurred with lower affinity. The conformation of the CREB-bZip or its position related to the DNA is presumably suboptimal in the GAL4-bZip construct used in the present study, suggesting that the CREB-TORC interaction is stabilized by CREB regions other than the bZip. Overexpression results in higher concentration of TORC in the nucleus, which could overcome these deficits. Thirdly, the somatostatin CRE in its homologous context was employed. The promoter contains the CRE which was used to create the oligomerized promoter in 4×SomCRET81Luc. Overexpression of TORC conferred the responsiveness of the native promoter to lithium, thus indicating that TORC was also mediating the lithium content in the homologous context.
What could be the consequences of these findings? Generally, lithium may be able to modulate the expression of CRE/CREBregulated genes [6] . The BDNF (brain-derived neurotrophic factor) gene and the anti-apoptotic Bcl-2 gene are regulated by CREB, which has been implicated in neuroprotective and neuroplasticity processes. It has been shown that lithium treatment increased expression of BDNF and Bcl-2 in rat hippocampus and cortex [10] , which has been considered to contribute to the neuroprotective action of lithium. Furthermore in the hippocampus it has been shown that TORC1 was essential for CREB-induced long-term potentiation, a form of synaptic plasticity involved in long-term-memory formation [16] . The hippocampus plays a pivotal role in the control of mood and emotion. In addition, hippocampal volume reduction was associated with bipolar disorder [38] . Thus one could assume that the mood-stabilizing action of lithium involves CRE/CREB-TORC-mediated gene expression, particularly in this brain region.
In the present study we provide evidence, for the first time, that lithium plays a direct role in the CRE/CREB-directed gene transcription. We have shown that, independently of interfering with signalling cascades, lithium directly affects CREB activity and we suggest that the coactivator TORC could be a new target for its molecular mechanism of action. This will not only deepen our understanding of the therapeutic action of lithium salts. It also provides new insight into the regulation of gene expression whereby the interplay between transcription factors and their coactivators can be modulated by ions such as lithium.
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